BORAGE INTRINSIC
Natural health product licensed in Canada
- Licence holder
- Aperture Energetics Inc.
- NPN or DIN-HM
- 80042698
- Status
- Active licence
- Licence date
- 6 June 2013
- Revision date
- Not provided
- Form
- Liquide
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Handroanthus impetiginosus Source : Extrait d'écorce Extraction ratio : 1:0.98 Dry plant equivalent : 64.1 mg | 0.0625 mL |
| Borago officinalis Source : Seed extract Extraction ratio : 1:0.98 Dry plant equivalent : 12.8 mg | 0.0125 mL |
| Borago officinalis Source : Seed extract Extraction ratio : 1:0.098 Dry plant equivalent : 429.4 mg | 0.4208 mL |
| Silybum marianum Source : Seed (standardized extract) Extraction ratio : 1:0.98 Dry plant equivalent : 16.8 mg Potency : 80 % silymarin | 0.0165 mL |
Non-medicinal ingredients
Eau purifiée, Éthanol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 mL | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants for the maintenance of good health. Source of essential fatty acids for the maintenance of good health. Source of omega-3 fatty acids for the maintenance of good health. Source of alpha-linolenic acid (ALA) for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80042698
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.